Related Experiment Video
Updated: Feb 9, 2026

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
[P2X7 receptor and inflammatory bowel disease]
1Experimental Training Center for Basic Medical Sciences, The Second Military Medical University, Shanghai 200433, China.
P2X7 receptors influence inflammation in the colon. While typically promoting inflammation in models, this review explores their inhibitory role in specific conditions like toxoplasmic ileitis, highlighting the need for further research in inflammatory bowel disease (IBD).
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- P2X7 receptors are expressed on colonic cells and linked to inflammation.
- ATP/P2X7 signaling generally promotes inflammation in animal models of colonic inflammation.
- The role of P2X7 signaling in toxoplasmic ileitis appears to be inhibitory, but mechanisms are unclear.
Purpose of the Study:
- To review current research on P2X7 receptors in inflammatory bowel disease (IBD).
- To elucidate the complex role of P2X7 signaling in gastrointestinal inflammation.
- To identify knowledge gaps regarding P2X7 receptor function in IBD pathogenesis.
Main Methods:
- Literature review of studies on P2X7 receptors and inflammation.
- Analysis of P2X7 receptor involvement in various cell types (macrophages, dendritic cells, T cells, mast cells, enteric neurons).
- Comparison of P2X7 signaling roles in different inflammatory conditions, including IBD and toxoplasmic ileitis.
Main Results:
- P2X7 receptors are broadly expressed in the colon.
- ATP/P2X7 signaling predominantly exacerbates inflammation in experimental colitis.
- Evidence suggests P2X7 signaling may suppress inflammation in toxoplasmic ileitis.
Conclusions:
- The function of P2X7 receptors in IBD is complex and context-dependent.
- Further investigation is required to understand the precise mechanisms of P2X7 receptor action in IBD.
- Targeting P2X7 receptors could offer novel therapeutic strategies for IBD.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

